PannTheraPi

Neurology and Epilepsy

Panntherapi’s clinical research activity is centered on epilepsy, with interest in the treatment and management of seizure disorders and related neurological symptoms.

  • Seizure control
  • Antiepileptic therapy
  • Neurological disorder management

The sponsor’s research focus reflects a targeted commitment to central nervous system therapeutics within the field of neurology.

Pharmacology and Drug Development

The funded trial activity also indicates an interest in pharmacokinetics and the clinical characterization of a therapeutic candidate for epilepsy.

  • Drug disposition
  • Clinical pharmacology
  • Therapeutic exposure assessment

This area supports evaluation of how a neurologic treatment behaves in the body, with attention to absorption, distribution, and elimination.

Safety Evaluation

Panntherapi’s research landscape includes clinical attention to safety in a neurological treatment setting, with focus on tolerability and adverse event monitoring in epilepsy.

  • Tolerability
  • Adverse event monitoring
  • Patient safety

This work aligns with clinical interest in establishing the risk profile of therapies intended for seizure-related conditions.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France